Paper - WANFANG MED ONLINE

You Position: Home > Paper

Late and very late stent thrombosis after polymer-based sirolimus-or paclitaxel-eluting

( views:144, downloads:8 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 7

DOI:: 10.3760/cma.j.issn.0366-6999.2010.07.001

Key Word:: No keyword available

Abstract： @@ Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation is superior, asopposed to bare-metal stenting, in terms of reduction of target lesion revascularization and improvement in clinical outcomes;~(1,2) the penetration rate of DES reached beyond 90% in routine PCI practice in China, especially with the availability of home-made polymer-based sirolimus- (Firebird, Excel or Partner) and non-polymer-based paclitaxel- (Yinyi) eluting stents.~(3,4)

Reference

[1]SHEN Wei-feng.Interventional therapy of coronary artery disease in China: retrospective and perspective[J].2008,(22).
[2]ZHANG Rui-yan,DU Run,ZHU Zheng-bin,etc.Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation[J].2008,(24).
[3].Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results[J].2010,(7).
[4]Mehilli,Schuster T,Schulz S.Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.[J].2009,30(22).
[5]Cox DA,Hermiller J,Turco M,etc.A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.[J].2004,350(3).
[6]Simon DI,Parikh SA.Hunting for the "sweet spot" in P2Y12 receptor blockade.[J].2009,54(15).
[7]Rassen JA,Choudhry NK,Avorn.Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome.[J].2009,120(23).
[8]Jaffe R,Strauss BH.Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.[J].2007,50(2).
[9]Sibbing D,Mehilli J,Schomig A,etc.Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.[J].2009,30(8).
[10]Kleschyov AL,Wenzel P,Oelze M,etc.Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation.[J].2008,51(22).
[11]Becker RC,Dauerman H,Scheiman J.Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.[J].2009,54(24).
[12]Wenaweser P,Daemen J,Zwahlen M,etc.Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.[J].2008,52(14).
[13]Mark Y. Chan,Felicita Andreotti,Richard C. Becker.Hypercoagulable States in Cardiovascular Disease[J].2008,118(22).
[14]Iakovou I,Schmidt T,Bonizzoni E,etc.Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.[J].2005,293(17).
[15]Braun S,Kastrati A,Mehilli J,etc.Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.[J].2009,53(10).
[16]Hu J,Yang ZK,Zhang Q,etc.Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.[J].2009,112(3).
[17]Schwartz RS,Nakazawa G,Wilson GJ.Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.[J].2009,120(2).
[18]Ma,Rodriguez-Collado J,Hernandez F,etc.Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos).[J].2008,51(10).
[19]Brueren BR,Zomer AC,ten Berg JM,etc.Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.[J].2009,53(16).
[20]de-Korte FI,Koolen JJ,ten-Berg JM,etc.Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.[J].2009,119(6).
[21]Montalescot G,Hulot JS,Collet JP.Stent thrombosis: who's guilty?[J].2009,30(22).
[22]Popma JJ,Leon MB,Caputo RP,etc.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.[J].2003,349(14).
[23]Simonenko,Geisler T,Zurn C.Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.[J].2010,31(1).